Roslin Cellab
Provides contract research, product development, and stem cell culture training using 3D bioprinting for drug testing and regenerative medicine applications.
- CEO / Founder
- Aidan Courtney
- Team Size
- 11-50
- Stage
- Acquired
- Total Funding
- £4.44M
- Latest Round
- Innovate UK Support - £3.5M - 2016+
- Key Investors
- Innovate UK; University of Edinburgh; Scottish National Blood Transfusion Service; Scottish Enterprise
Technology & Products
Key Products
iPSC-based neuroscience, immune cell, and cardiac modeling for drug discovery
Technological Advantage
Proprietary valve-based bioprinting process tailored for delicate hESCs, developed in collaboration with Heriot-Watt University, allowing precise deposition of living cells that survive printing and retain differentiation potential.
Differentiation
Value Proposition
Enables pharmaceutical and biotech companies to accelerate drug discovery and toxicity testing by providing 3D-printed human stem cell tissues that mimic in vivo conditions, reducing reliance on animal models and improving predictive accuracy.
How They Differentiate
Part of Censo Biotechnologies (formed by merger of Roslin Cellab and Roslin Cell Sciences in 2016), specializing in iPSC-based neuroscience, immune cell, and cardiac modeling for drug discovery with Innovate UK backing, differentiating from broader bioprinting companies like CELLINK.
Market & Competition
Target Customers
Academic and commercial clients in life sciences, biotechnology, and pharmaceutical sectors
Industry Verticals
Life Sciences; Biotechnology; Pharmaceuticals
Competitors
CELLINK, Axol Bioscience
Growth & Milestones
Growth Metrics
Merged with Roslin Cell Sciences in 2016 to form Censo Biotechnologies Group; Received £117,432 in grant funding for a liver cell project; Over 190,000 people reached through media coverage of 3D bioprinting work
Major Milestones
2013: World-first 3D printing of human embryonic stem cells in collaboration with Heriot-Watt University; 2016: Merged with Roslin Cell Sciences to form Censo Biotechnologies
Notable Customers
Reinnervate Ltd; BioCision